These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 8786537

  • 1. Stimulation of renin secretion by the phosphodiesterase IV inhibitor rolipram.
    Chiu N, Park I, Reid IA.
    J Pharmacol Exp Ther; 1996 Mar; 276(3):1073-7. PubMed ID: 8786537
    [Abstract] [Full Text] [Related]

  • 2. Role of cyclic GMP-inhibitable phosphodiesterase and nitric oxide in the beta adrenoceptor control of renin secretion.
    Chiu T, Reid IA.
    J Pharmacol Exp Ther; 1996 Aug; 278(2):793-9. PubMed ID: 8768733
    [Abstract] [Full Text] [Related]

  • 3. An effect of extrarenal beta adrenergic stimulation on the release of renin.
    Reid IA, Schrier RW, Earley LE.
    J Clin Invest; 1972 Jul; 51(7):1861-9. PubMed ID: 4402350
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of phosphodiesterase III with milrinone increases renin secretion in human subjects.
    Chiu YJ, Hu SH, Reid IA.
    J Pharmacol Exp Ther; 1999 Jul; 290(1):16-9. PubMed ID: 10381754
    [Abstract] [Full Text] [Related]

  • 5. Effects of rolipram and cilostamide on renal functions and cyclic AMP release in anesthetized dogs.
    Tanahashi M, Hara S, Yoshida M, Suzuki-Kusaba M, Hisa H, Satoh S.
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1533-8. PubMed ID: 10336549
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Conditions for augmentation of renin release by theophylline.
    Langård O, Holdaas H, Eide I, Kiil F.
    Scand J Clin Lab Invest; 1983 Feb; 43(1):9-14. PubMed ID: 6312554
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Identification, characterization, and functional role of phosphodiesterase type IV in cerebral vessels: effects of selective phosphodiesterase inhibitors.
    Willette RN, Shiloh AO, Sauermelch CF, Sulpizio A, Michell MP, Cieslinski LB, Torphy TJ, Ohlstein EH.
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):210-9. PubMed ID: 9040501
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The influence of endogenous catecholamines on the inhibitory effects of rolipram against early- and late-phase response to antigen in the guinea pig.
    Underwood DC, Matthews JK, Osborn RR, Bochnowicz S, Torphy TJ.
    J Pharmacol Exp Ther; 1997 Jan; 280(1):210-9. PubMed ID: 8996198
    [Abstract] [Full Text] [Related]

  • 15. Phosphodiesterase inhibition by naloxone augments the inotropic actions of beta-adrenergic stimulation.
    Park WK, Chang CH, Chae JE, Kim MH, Cho YL, Ahn DS.
    Acta Anaesthesiol Scand; 2009 Sep; 53(8):1043-51. PubMed ID: 19572940
    [Abstract] [Full Text] [Related]

  • 16. Role of nitric oxide in the renin and heart rate responses to beta-adrenergic stimulation.
    Reid IA, Bui H, Chou L.
    Hypertension; 1994 Jan; 23(1 Suppl):I49-53. PubMed ID: 8282375
    [Abstract] [Full Text] [Related]

  • 17. Stimulation of renin secretion by nitric oxide is mediated by phosphodiesterase 3.
    Kurtz A, Götz KH, Hamann M, Wagner C.
    Proc Natl Acad Sci U S A; 1998 Apr 14; 95(8):4743-7. PubMed ID: 9539809
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Imaging of cAMP-specific phosphodiesterase-IV: comparison of [11C]rolipram and [11C]Ro 20-1724 in rats.
    Lourenco CM, DaSilva JN, Warsh JJ, Wilson AA, Houle S.
    Synapse; 1999 Jan 14; 31(1):41-50. PubMed ID: 10025682
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.